Treace Medical Concepts Inc (TMCI) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.75 is considered Undervalued compared with the five-year average of -31.14. The fair price of Treace Medical Concepts Inc (TMCI) is between 48.73 to 63.40 according to relative valuation method. Compared to the current price of 1.71 USD , Treace Medical Concepts Inc By Undervalued By 96.49%.

Relative Value

Fair Zone

48.73-63.40

Current Price：1.71

96.49%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Treace Medical Concepts Inc (TMCI) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Treace Medical Concepts Inc (TMCI) has a current Price-to-Book (P/B) ratio of 1.79. Compared to its 3-year average P/B ratio of 5.57, the current P/B ratio is approximately -67.93% higher. Relative to its 5-year average P/B ratio of 2.93, the current P/B ratio is about -39.07% higher. Treace Medical Concepts Inc (TMCI) has a Forward Free Cash Flow (FCF) yield of approximately -16.54%. Compared to its 3-year average FCF yield of -7.95%, the current FCF yield is approximately 107.99% lower. Relative to its 5-year average FCF yield of -5.64%, the current FCF yield is about 193.38% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for TMCI competitors is 87.69, providing a benchmark for relative valuation. Treace Medical Concepts Inc Corp (TMCI.O) exhibits a P/S ratio of 0.75, which is -99.14% above the industry average. Given its robust revenue growth of -9.01%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of TMCI increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of TMCI in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is TMCI currently overvalued or undervalued?

Treace Medical Concepts Inc (TMCI) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.75 is considered Undervalued compared with the five-year average of -31.14. The fair price of Treace Medical Concepts Inc (TMCI) is between 48.73 to 63.40 according to relative valuation method. Compared to the current price of 1.71 USD, Treace Medical Concepts Inc is Undervalued By 96.49%.

What is Treace Medical Concepts Inc (TMCI) fair value?

TMCI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Treace Medical Concepts Inc (TMCI) is between 48.73 to 63.40 according to relative valuation method.

How does TMCI's valuation metrics compare to the industry average?

The average P/S ratio for TMCI's competitors is 87.69, providing a benchmark for relative valuation. Treace Medical Concepts Inc Corp (TMCI) exhibits a P/S ratio of 0.75, which is -99.14% above the industry average. Given its robust revenue growth of -9.01%, this premium appears unsustainable.

What is the current P/B ratio for Treace Medical Concepts Inc (TMCI) as of Mar 02 2026?

As of Mar 02 2026, Treace Medical Concepts Inc (TMCI) has a P/B ratio of 1.79. This indicates that the market values TMCI at 1.79 times its book value.

What is the current FCF Yield for Treace Medical Concepts Inc (TMCI) as of Mar 02 2026?

As of Mar 02 2026, Treace Medical Concepts Inc (TMCI) has a FCF Yield of -16.54%. This means that for every dollar of Treace Medical Concepts Inc's market capitalization, the company generates -16.54 cents in free cash flow.

What is the current Forward P/E ratio for Treace Medical Concepts Inc (TMCI) as of Mar 02 2026?

As of Mar 02 2026, Treace Medical Concepts Inc (TMCI) has a Forward P/E ratio of -2.83. This means the market is willing to pay $-2.83 for every dollar of Treace Medical Concepts Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Treace Medical Concepts Inc (TMCI) as of Mar 02 2026?

As of Mar 02 2026, Treace Medical Concepts Inc (TMCI) has a Forward P/S ratio of 0.75. This means the market is valuing TMCI at $0.75 for every dollar of expected revenue over the next 12 months.

TMCI Valuation